While this allows for customized formulations, it also means these medications are not subject to the same level of scrutiny as FDA-approved drugs
[3] Wang HaiLi,Zhang Jun,Li YuPing,Dong Lun,Chen YingZhu
The study looked back on their health records for up to three years, beginning when they started taking either a GLP-1 receptor agonist most commonly semaglutide, liraglutide or dulaglutide or another type of medication, called an SGLT2 inhibitor, to treat their diabetes
To understand how semaglutide affects the body, it helps to look at how GLP-1 receptor agonists work
It also carries theoretical angiogenic risksmeaning it promotes blood vessel growth, which is great for a torn tendon, but terrible if you have an active malignancy or history of cancer